Therefore it may be that a goal of treatment should be to ensure adequate but not excessive Th-17 response to RSV infection.[6] We speculate that this may also be the case for Il-13, where some mucous increases respiratory epithelium resilience against infection but excessive amounts lead to mucous plugging and increased work of breathing. This evidence concerns the gene IL13 and infection.